Clinical Application of Portable Intelligent Multi Joint Isokinetic Training and Evaluation System Technology
NCT ID: NCT06153992
Last Updated: 2023-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
90 participants
INTERVENTIONAL
2024-01-01
2024-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
The control group received exercise therapy (once a day, 40min/ times, 5 times/week), occupational therapy (once a day, 30min/ times, 5 times/week), low-frequency electricity (once a day, 20min/ times, 5 times/week), acupuncture therapy (once a day, 20min/ times, 5 times/week) .
without test training
Treatment was performed without using any isokinetic muscle strength test training system
Traditional isokinetic treatment group
The treatment machine adopts the traditional isokinetic training machine, the treatment items and the treatment parameters are the same as the intelligent isokinetic treatment group.
isokinetic muscle strength test training
The isokinetic training of knee flexors and extensors was carried out by using isokinetic muscle strength test training system
without test training
Treatment was performed without using any isokinetic muscle strength test training system
Intelligent isokinetic treatment group
In the intelligent isokinetic treatment group, isokinetic muscle strength training of hemiplegic lower limb flexion muscle group and knee extension muscle group was added to the treatment of the control group.
Intelligent isokinetic treatment to increase the above treatment hemiplegic lower limb flexion, knee extension muscle isokinetic strength training. The patient's seat back was adjusted to 85° and fixed with a belt and shoulder cross-strap. The thigh of the subject was fixed with a nylon buckle, the lateral condyle of the femur was the axis, the lever arm length was scale 12, and the distal leg was fixed above the ankle. Passive joint activities were performed on the knee and ankle before training. Avoid joint damage and perform three low-resistance warm-up exercises. Choose 60°/s, 90°/s, 120°/s angular speed isokinetic training according to the patient's specific conditions. Each angular speed training is 10 times, the interval rest is 15s.ect.
Intelligent portable isokinetic muscle strength test training
The isokinetic training of knee flexors and extensors was carried out by using intelligent portable isokinetic muscle strength test training system
without test training
Treatment was performed without using any isokinetic muscle strength test training system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intelligent portable isokinetic muscle strength test training
The isokinetic training of knee flexors and extensors was carried out by using intelligent portable isokinetic muscle strength test training system
isokinetic muscle strength test training
The isokinetic training of knee flexors and extensors was carried out by using isokinetic muscle strength test training system
without test training
Treatment was performed without using any isokinetic muscle strength test training system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed by CT or MR Examination of the head
* First onset, duration ≤1 month
* The lower extremity of the hemiplegic limb was above Brunnstrom stage III
* Must be able to sign the informed consent form
Exclusion Criteria
* Severe cognitive, visual and hearing impairment
* Orthopaedic disease
* Muscle pain lower extremity
* Congenital disease
* History of other encephalopathy
* History of mental illness
25 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ran Shi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ran Shi
doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sanyuan Hu, doctor
Role: STUDY_CHAIR
Qianfoshan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Intelligent Multi Joint Isokinetic
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
docter
Role: primary
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021004
Identifier Type: -
Identifier Source: org_study_id